View Post

Patients of African descent are being denied the benefits of cancer breakthroughs. We’re changing that

In Clinical Trials by Barbara Jacoby

By: Jennifer Dent From: statnews.com Death rates from cancer are falling and access to potentially lifesaving treatments is increasing — except among Africans and Americans of African descent. This gap must be closed. Overall, the picture for cancer looks better than it did 30 years ago. In the last two decades, death rates for cancer in the U.S. have declined …

View Post

‘Click chemistry’ reactions may boost cancer-fighting drug potency

In In The News by Barbara Jacoby

Source: Scripps Research Institute From: sciencedaily.com Researchers at The Scripps Research Institute (TSRI) have developed a quick and easy way to simultaneously modify dozens of drugs or molecules to improve their disease-fighting properties. Using the approach, scientists exchanged one chemical group for another in 39 cancer drugs — and discovered under lab conditions that the chemically altered versions of three …

View Post

Laws To Control Cancer Drug Costs Don’t Help Patients With Highest Expenses

In In The News by Barbara Jacoby

By: Arlene Weintraub From: forbes.com When state legislators started enacting laws in 2011 to prevent insurance companies from charging patients more for oral cancer drugs than they do for cheaper, infused medicines, the idea was to shield the public from sky-high, out-of-pocket drug costs. But a new study is raising disturbing questions about the effectiveness of these “parity” laws, which have been …

View Post

Attention turning toward ‘miracle’ cancer patients

In In The News by Barbara Jacoby

By: Erin Blakemore From: pressherald.com Call it luck – or a medical miracle. During clinical trials for experimental cancer drugs, some patients simply respond better than others. And a tiny fraction of patients see dramatic results, responding so well to treatment that they survive forms of cancers that quickly kill their counterparts. Stories about people like Emily Whitehead, the then-6-year-old …

View Post

Pfizer boosts cancer drug roster with $14 billion Medivation deal

In In The News by Barbara Jacoby

By: Ransdell Pierson and Ankur Banerjee From: reuters.com Pfizer Inc (PFE.N), beating out numerous other bidders, said it agreed to buy U.S. cancer drug company Medivation Inc (MDVN.O) for $14 billion in cash, adding its blockbuster prostate cancer drug Xtandi to the company’s growing oncology roster. Medivation shares jumped nearly 20 percent to close at $80.42, just shy of the …

View Post

Here are some ways cancer can thwart the new immunotherapy drugs

In In The News by Barbara Jacoby

119By: Laurie McGinley From: washingtonpost.com A new type of cancer drug designed to unleash the immune system is revolutionizing treatment for advanced melanoma, lung cancer and other malignancies. But some patients who initially respond to the therapy relapse, and researchers are anxious to figure out how and why the delayed resistance occurs. “Does the immune system stop working, or does …

View Post

Scientists provide proof of concept for potential new class of cancer drugs

In In The News by Barbara Jacoby

Source: University of Miami Miller School of Medicine From: sciencedaily.com A recent study led by scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, in collaboration with the Univerity of Maryland School of Pharmacy and StemSynergy Therapeutics, Inc., has identified a small-molecule inhibitor of the Notch pathway, paving the way for a potential new …

View Post

10 Outrageous Cancer Drug Statistics

In In The News by Barbara Jacoby

From: fool.com A new report from the IMS Institute for Health Informatics highlights the plights and promises of the rapidly growing cancer drug industry. In terms of diagnoses, there’s arguably nothing scarier a patient can hear than the phrase, “you have cancer.” According to statistics from the World Health Organization, some 14 million cases of cancer are diagnosed annually, and …